Combined Oral Contraceptive: Regret, Stopping, and Restarting

Why Women Stop the Pill (and Then Regret It)

Stopping a combined oral contraceptive is one of the most common decisions women make about their reproductive health, and the reasons cut in both directions. Some women stop because of side effects and later miss the benefits. Others stop to conceive or to "give their body a break," then realize the symptoms that returned were worse than whatever the pill was managing.

Data from the Guttmacher Institute show that approximately 31% of pill users discontinue within the first year, making the COC one of the highest-discontinuation methods despite being the most commonly prescribed. Understanding why is the first step to making a more durable choice the second time around.

The Most Reported Reasons for Stopping

Across self-reported platforms including Reddit's r/birthcontrol community, Drugs.com reviews, and published patient-reported outcome studies, the most consistent reasons women stop COCs are:

• Mood changes and depression. A 2016 Danish cohort study of more than one million women published in JAMA Psychiatry found that hormonal contraceptive use was associated with a subsequent diagnosis of depression and antidepressant use, with adolescents showing a higher relative risk than adult women.
• Low libido. Ethinyl estradiol suppresses hepatic sex hormone-binding globulin (SHBG) production in a paradoxical direction: SHBG rises sharply on the pill, binding free testosterone and reducing the androgen available to drive desire. Studies show SHBG can remain elevated for months after stopping in some women, a phenomenon sometimes called "post-pill SHBG syndrome," though this term is not yet a formal clinical diagnosis.
• Breakthrough bleeding. Unscheduled bleeding is the leading cause of early discontinuation in real-world populations and is often a sign of progestin-dose mismatch rather than a reason to abandon COCs entirely.
• Weight and bloating concerns. Trial data generally do not confirm significant weight gain with modern low-dose COCs, but patient-reported experience frequently conflicts with that finding. The disconnect matters clinically: dismissing a woman's reported experience accelerates dropout.

What Women Regret After Stopping

The flip side is real too. Women who stop the pill to "feel more like themselves" sometimes find that the mood symptoms they attributed to the pill were actually the underlying cycle itself returning. Premenstrual dysphoric disorder (PMDD), severe cramping from endometriosis, or worsening acne and hirsutism from untreated PCOS can resurface quickly.

ACOG Practice Bulletin No. 206 notes that COCs are a first-line treatment for dysmenorrhea, endometriosis-related pain, and menstrual suppression, and discontinuing without an alternative plan leaves these conditions unmanaged. Women with PCOS in particular often report a return of irregular cycles, worsening acne, and hair loss within two to three months of stopping.

What Actually Happens to Your Body When You Stop

Stopping is not dangerous. The hormones clear your system within days. But what follows can feel dramatic, and knowing what is physiological versus what is a signal to investigate helps you stay calm and informed.

Hormone Withdrawal in the First Month

Within 24 to 48 hours of your last active pill, the synthetic estrogen and progestin levels drop. Your hypothalamic-pituitary-ovarian (HPO) axis, which has been suppressed by exogenous hormones, begins to reactivate. This reactivation is not instantaneous.

For most women, the first natural ovulation occurs within 2 to 6 weeks of stopping, though women who had irregular cycles before starting the pill may take longer. That early post-pill period is not a safe window for unprotected sex if you want to avoid pregnancy.

Post-Pill Cycle Changes

Your first "period" after stopping is technically a withdrawal bleed from the pill, not a true menstrual cycle. A true period, driven by your own ovulation, may arrive four to eight weeks later. This gap is normal and does not indicate a problem.

A 2018 study in Obstetrics and Gynecology found that 85% of women conceived within 12 months of stopping COCs, a rate that is statistically similar to women who had never used hormonal contraception. The old idea that the pill "damages" fertility is not supported by current evidence.

Conditions That May Resurface

Some conditions are suppressed rather than treated by the pill. When you stop:

• PCOS: Anovulatory cycles, elevated androgens, and irregular periods typically return. If you were prescribed the pill primarily for PCOS management without addressing insulin resistance or LH/FSH dysregulation, restarting without that conversation does not resolve the root issue.
• Endometriosis: Lesion activity can resume. Pain may return within one to three cycles.
• Acne: Androgenic rebound is common in the first one to three months. Some formulations (drospirenone/EE, norgestimate/EE) have FDA-cleared indications for acne treatment. Stopping those without an alternative androgen-suppressing plan often leads to a flare.
• Menstrual migraines: Some women find migraines worsen in the withdrawal-bleed week. Others find natural cycling is better. This varies significantly by individual.

Who This Is Right For, and Who Should Reconsider

Good Candidates for Restarting a COC

You are a reasonable candidate for restarting a combined oral contraceptive if:

• You are a non-smoker under 35, or a non-smoker of any age without cardiovascular risk factors
• Your blood pressure is below 140/90 mmHg
• You stopped because of nuisance side effects that may be formulation-specific (breakthrough bleeding, mood fluctuation, low libido) rather than class-wide effects
• You are managing acne, dysmenorrhea, endometriosis, or PCOS symptoms and stopped without an alternative plan
• You are in your reproductive years and want reliable contraception (COCs are more than 99% effective with perfect use, approximately 91% with typical use)

Situations That Warrant a Different Plan

COCs are not appropriate, or require careful specialist review, if you:

• Have a personal or strong family history of venous thromboembolism (VTE). The absolute VTE risk with COC use is approximately 3 to 9 per 10,000 woman-years, compared with 1 to 5 per 10,000 in non-users, and significantly higher during pregnancy itself.
• Smoke cigarettes and are 35 or older. This combination is a WHO Medical Eligibility Criteria Category 4 (absolute contraindication).
• Have migraine with aura. Estrogen-containing contraceptives increase stroke risk in this group. ACOG and the WHO both classify migraine with aura as a Category 3 or 4 condition depending on context.
• Are in perimenopause with cardiovascular risk factors. Low-dose COCs can be used into the late 40s in healthy non-smoking women, but the risk-benefit calculation changes. A progestin-only pill or an IUD plus low-dose estrogen may be more appropriate.
• Are trying to conceive. Stop the pill, confirm ovulation return (basal body temperature or a urine LH test), and switch to prenatal folic acid at 400 to 800 mcg daily before conception.

Life-Stage Considerations

Reproductive Years (18-35)

This is the age range most COC data is based on. Formulation choice is wide. If your previous pill caused low libido or mood changes, switching from a pill with a more androgenic progestin (levonorgestrel) to one with a neutral or anti-androgenic progestin (drospirenone or dienogest, though dienogest is not available in the US as a standalone COC) may help. A 2022 Cochrane review found that direct head-to-head comparisons between progestins for mood outcomes remain limited, so prescribing is still partly trial-and-error.

Trying to Conceive (TTC)

Stop the pill at least one full cycle before your target conception window so you can track your natural cycle. Most women do not need to wait. The American Society for Reproductive Medicine (ASRM) finds no evidence that immediate conception after stopping COCs increases miscarriage risk. Take folic acid before you stop, not after.

Postpartum and Lactation

Combined oral contraceptives are not recommended during breastfeeding. Ethinyl estradiol reduces milk supply, and the CDC Medical Eligibility Criteria for Contraceptive Use categorizes estrogen-containing methods as Category 4 (not to be used) in the first 30 days postpartum, and Category 3 (risks generally outweigh benefits) from 30 days to 6 months if breastfeeding. Use a progestin-only pill, an IUD, or an implant instead.

Perimenopause (Typically 45-52)

Low-dose COCs can mask perimenopausal symptoms by creating a regular withdrawal bleed, which means you may not realize you have entered perimenopause until you stop. If you are over 50 and want to know whether you are in menopause, stop the pill for six to eight weeks and test FSH. Do not use FSH to assess menopausal status while on a COC: the result will be suppressed and unreliable. The Menopause Society (formerly NAMS) notes that COCs can be continued in healthy, non-smoking perimenopausal women as contraception and vasomotor symptom management.

Pregnancy and Lactation Safety

Pregnancy: Combined oral contraceptives must be stopped immediately if you discover you are pregnant. Early inadvertent exposure to COCs during the first trimester has not been conclusively linked to fetal malformations in large observational studies, but there is no therapeutic reason to continue them in pregnancy and they should be stopped without delay. The FDA removed the black-box warning about first-trimester exposure in 1990 based on the weight of evidence, but this does not mean they are safe to use in pregnancy: the indication simply does not exist.

Lactation: As noted above, estrogen-containing pills are not recommended while breastfeeding due to milk-supply reduction. The CDC MEC classifies combined hormonal contraceptives as Category 3 from 1 to 6 months postpartum in breastfeeding women. Progestin-only options do not have the same restriction.

Teratogen note: COCs are not classified as teratogens based on current epidemiological data, but stopping is the correct action the moment a positive pregnancy test is confirmed.

How to Restart Safely

Restarting a COC after a break is medically simple, but a few steps improve both safety and the chance you will stick with it this time.

Step 1: Rule Out Pregnancy

Before restarting, take a urine pregnancy test if there is any chance of pregnancy from unprotected sex since stopping. This is not a formality: starting a COC during early pregnancy delays diagnosis and is unnecessary exposure.

Step 2: Choose Your Start Method

Two evidence-based start methods exist:

• Day 1 start: Begin on the first day of your natural period. No backup contraception needed.
• Quick-start (same-day start): Begin on any day of your cycle after confirming a negative pregnancy test. Use a backup method (condoms) for the first seven days, and take a repeat pregnancy test in two to four weeks. ACOG supports quick-start as a strategy to reduce the gap between prescription and initiation.

Step 3: Address the Reason You Stopped

This is the step most clinicians skip. If mood was the issue, document which formulation you were on and consider switching progestin type or lowering the ethinyl estradiol dose (some women do better on 20 mcg EE than 30-35 mcg). If libido was the primary concern, a small but real body of evidence suggests drospirenone-containing pills may have a less negative impact on SHBG than levonorgestrel-containing ones, though head-to-head libido trials in women are limited.

Step 4: Set a Review Date

Book a follow-up at six to eight weeks. Most side effects that will appear have appeared by then. Having a scheduled check-in reduces the chance you quietly stop again without finding a formulation that works.

What Real Women Say: Synthesized From Community Experience

Across hundreds of posts in r/birthcontrol, Drugs.com reviews, and patient forums, four patterns appear repeatedly. These are not cherry-picked testimonials: they represent the distribution of reported experiences.

Pattern 1: "I stopped because of mood, then realized the pill wasn't the problem." A significant minority of women who attribute low mood or anxiety to their pill find that these symptoms persist or worsen after stopping. For some, the COC was actually stabilizing hormonal fluctuations that drive premenstrual mood changes. Stopping without tracking symptoms carefully makes it hard to identify the true driver.

Pattern 2: "I switched formulations instead of stopping and things improved." Women who worked with a clinician to switch from a higher-androgen progestin pill to a drospirenone- or norgestimate-containing product frequently report improvement in both mood and acne without losing contraceptive protection. Stopping entirely is often unnecessary if the issue is formulation-specific.

Pattern 3: "I stopped to feel 'natural,' then my PCOS symptoms came back hard." Women with PCOS who stop without addressing the underlying metabolic and androgen-excess picture are particularly vulnerable to rapid symptom return. Hair shedding, acne flares, and cycle irregularity within eight to twelve weeks are common reports. This group benefits most from a structured plan before stopping, not after.

Pattern 4: "Restarting was easier than I expected, and I wished I had done it sooner." For women who stopped due to external pressure, social media fear, or a vague sense that "hormones are bad," restarting after a documented conversation with a clinician often went smoothly. Choosing a different formulation with the benefit of knowing their own history made adherence easier.

A Note on the Evidence Gap

The COC has been studied for more than 60 years, making it one of the most researched drugs in existence. Yet specific data on restart strategies after intentional discontinuation, the optimal formulation switch for mood or libido, and post-pill SHBG trajectory in individual women remain limited. Women were underrepresented in early pharmacological trials across many drug classes, and contraception research, while women-specific, has historically prioritized efficacy over patient-reported quality of life outcomes. When a clinician tells you "the evidence doesn't support that side effect," it may mean the specific trial was never done, not that your experience isn't real.

Ask your prescriber: "What does the evidence say, and where is there genuine uncertainty?" That question will tell you a great deal about the quality of care you are receiving.

Practical Checklist Before Stopping or Restarting

| Step | Action | |---|---| | Before stopping | Identify the specific symptom driving your decision | | Before stopping | Ask whether a formulation switch could address it | | Before stopping | Plan for the conditions the pill was managing (acne, PCOS, dysmenorrhea) | | Before restarting | Rule out pregnancy | | Before restarting | Review blood pressure | | Before restarting | Discuss migraine status with your clinician | | Before restarting | Choose start method (Day 1 or Quick-Start) | | After restarting | Schedule a 6-8 week follow-up | | If breastfeeding | Choose progestin-only or non-hormonal method instead |